Reversible Cardiomyopathy Associated with Multicentric Castleman Disease: Successful Treatment with Tocilizumab, an Anti-Interleukin 6 Receptor Antibody-Reference-Cited by-同舟云学术

Reversible Cardiomyopathy Associated with Multicentric Castleman Disease: Successful Treatment with Tocilizumab, an Anti-Interleukin 6 Receptor Antibody

Published:2007-04-01 Issue:3 Volume:85 Page:207-211
ISSN:0925-5710
Container-title:International Journal of Hematology
language:
Short-container-title:International Journal of Hematology

Author:

Kanda Junya,Kawabata Hiroshi,Yamaji Yuhei,Ichinohe Tatsuo,Ishikawa Takayuki,Tamura Toshihiro,Furukawa Yutaka,Kimura Takeshi,Kita Toru,Uchiyama Takashi

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://www.springerlink.com/index/pdf/10.1532/IJH97.06186

Reference26 articles.

1. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 1956;9:822-830.

2. Waterston A, Bower M. Fifty years of multicentric Castleman's disease. Acta Oncol. 2004;43:698-704.

3. Yoshizaki K, Matsuda T, Nishimoto N, et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood. 1989;74:1360-1367.

4. Nishimoto N, Kanakura Y, Aozasa K, et al. Humanized antiinterleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood. 2005;106:2627-2632.

5. Fukuchi M, Nozaki S, Fukushima J, et al. Multicentric Castleman disease associated with congestive heart failure [in Japanese]. Cardioangiology. 2003;54:251-256.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epstein–Barr Virus-Positive Cutaneous and Systemic Plasmacytosis with TAFRO Syndrome-like Symptoms Successfully Treated with Rituximab;Medicina;2023-01-23

2. Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol;European Heart Journal: Acute Cardiovascular Care;2020-04

3. Clinicopathologic characteristics of 342 patients with multicentric Castleman disease in Japan;Modern Rheumatology;2020-01-22

4. Severe refractory TAFRO syndrome requiring continuous renal replacement therapy complicated with Trichosporon asahii infection in the lungs and myocardial infarction: an autopsy case report and literature review;Renal Replacement Therapy;2018-04-04

5. Short-term application of tocilizumab during myocardial infarction (STAT-MI);Rheumatology International;2017-10-24